疼痛管理薬&装置の世界市場見通し:癌性疼痛、顔面痛、頭痛、筋骨格痛、神経障害性疼痛

調査会社Stratistics MRC社が発行したリサーチレポート(データ管理コード:SMRC611059)
◆英語タイトル:Pain Management Drugs and Devices - Global Market Outlook (2016-2022)
◆発行会社/調査会社:Stratistics MRC
◆商品コード:SMRC611059
◆発行日:2016年10月
◆調査対象地域:グローバル
◆産業分野:医療
◆ページ数:139
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール
◆販売価格オプション(消費税別)
Single UserUSD4,150 ⇒換算¥452,350見積依頼/購入/質問フォーム
2-5 UserUSD5,250 ⇒換算¥572,250見積依頼/購入/質問フォーム
Global Site LicenseUSD7,500 ⇒換算¥817,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
Stratistics MRC社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[疼痛管理薬&装置の世界市場見通し:癌性疼痛、顔面痛、頭痛、筋骨格痛、神経障害性疼痛]についてメールでお問い合わせはこちら
当調査レポートでは、疼痛管理薬&装置の世界市場について調査・分析し、疼痛管理薬&装置の世界市場規模、市場動向、関連企業分析などを含め、以下の構成でお届けいたします。
・エグゼクティブサマリー
・序文
・疼痛管理薬&装置の世界市場:市場動向分析
・疼痛管理薬&装置の世界市場:競争要因分析
・疼痛管理薬&装置の世界市場:セグメント別分析/市場規模
・疼痛管理薬&装置の世界市場:地域別分析/市場規模
・疼痛管理薬&装置の北米市場規模
・疼痛管理薬&装置の欧州市場規模
・疼痛管理薬&装置のアジア市場規模
・疼痛管理薬&装置の世界市場:主な市場開拓
・関連企業分析
*** レポート概要(サマリー)***

According to Stratistics MRC, the Global Pain Management Drugs and Devices market is expected to grow from $39.48 billion in 2015 to reach $58.2 billion by 2022 with a CAGR of 5.7%. Growing various pain disorders coupled with increasing global geriatric people is the major factor propelling the pain management drugs and devices market. Furthermore, rapid technological developments, growing healthcare industry across the globe are some of the factors boosting the market growth. However, intensified competition between companies and lack of skilled professionals are the factors inhibiting the market growth.

The Neuromodulation device leads the market globally with the biggest market share and is expected to grow with a high CAGR during the forecast period. The growth of this segment is attributed to increasing chronic back pain. By drugs, opiods segment commands the market accounting for more than 42% of the total market. North America is anticipated to hold the largest share in global pain management drugs and devices market due to increasing demand from U.S. and Asia Pacific is likely to grow at a fastest rate during the forecast period.

Some of the key players in global pain management drugs and devices market include Abbvie Inc., Astrazeneca Depomed Inc., B. Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corporation, Eli Lilly & Co., Glaxosmithkline, Halyard Health, Inc., Hisamitsu Pharmaceutical Co. Inc, Johnson & Johnson, Medtronic Inc., Medtronic PLC, Neurotech Na, Inc. (A Subsidiary of Theragen LLC), Nevro Corp., Novartis International Ag, Pfizer, Purdue Pharmaceuticals Lp, Smiths Medical, and ST. Jude Medical, Inc.

Drug Classes Covered:
• Anti-Migraine Agents
• Non-Narcotic Analgesics
• Opioids
• NSAIDS
• Anesthetics
• Anticovulsants
• Antidepressent

Device Types Covered:
• Analgesic Infusion Pumps
o External Infusion Pumps
o Intrathecal Infusion Pumps
• Ablation Devices
o Cryoablation Devices
o Radiofrequency Ablation Devices
• Electrical stimulation devices
o Neuromuscular Electrical Stimulation (NMES/EMS) Devices
o Transcutaneous Electrical Nerve Stimulation (TENS) Devices
o Other Electrical Stimulation Devices
• Neuromodulation Devices
o Sacral Nerve Stimulation Devices
o Deep Brain Stimulation Devices
o Vagus Nerve Stimulation Devices
o Spinal Cord Stimulation (SCS) Devices

Indications Covered:
• Arthritic pain
• Cancer pain
• Migraine
• Fibromyalgia
• Chronic back pain
• Neuropathic pain
• Post-operative pain

Applications Covered:
• Cancer Pain
• Facial Pain and Migraine
• Musculoskeletal Pain
• Neuropathic Pain
• Other Applications
o Post-operative Pain
o Pregnancy/Labor and Menstrual Pain
o Sports Injuries
o Trauma Pain

Mode of Purchase Covered:
• Prescription-based Devices
• Over-the-counter Devices

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
• Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

*** レポート目次(コンテンツ)***

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 Emerging Markets

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Pain Management Drugs and Devices Market, By Drug Class
5.1 Introduction
5.2 Anti-Migraine Agents
5.3 Non-Narcotic Analgesics
5.4 Opioids
5.5 NSAIDS
5.6 Anesthetics
5.7 Anticovulsants
5.8 Antidepressent

6 Global Pain Management Drugs and Devices Market, By Device Type
6.1 Introduction
6.2 Analgesic Infusion Pumps
6.2.1 External Infusion Pumps
6.2.2 Intrathecal Infusion Pumps
6.3 Ablation Devices
6.3.1 Cryoablation Devices
6.3.2 Radiofrequency Ablation Devices
6.4 Electrical stimulation devices
6.4.1 Neuromuscular Electrical Stimulation (NMES/EMS) Devices
6.4.2 Transcutaneous Electrical Nerve Stimulation (TENS) Devices
6.4.3 Other Electrical Stimulation Devices
6.4.3.1 Combination Devices
6.4.3.2 TMS
6.4.3.3 Electrotherapy Devices
6.4.3.4 TNS
6.5 Neuromodulation Devices
6.5.1 Sacral Nerve Stimulation Devices
6.5.2 Deep Brain Stimulation Devices
6.5.3 Vagus Nerve Stimulation Devices
6.5.4 Spinal Cord Stimulation (SCS) Devices

7 Global Pain Management Drugs and Devices Market, By Indications
7.1 Introduction
7.2 Arthritic pain
7.3 Cancer pain
7.4 Migraine
7.5 Fibromyalgia
7.6 Chronic back pain
7.7 Neuropathic pain
7.8 Post-operative pain

8 Global Pain Management Drugs and Devices Market, By Application
8.1 Introduction
8.2 Cancer Pain
8.3 Facial Pain and Migraine
8.4 Musculoskeletal Pain
8.5 Neuropathic Pain
8.6 Other Applications
8.6.1 Post-operative Pain
8.6.2 Pregnancy/Labor and Menstrual Pain
8.6.3 Sports Injuries
8.6.4 Trauma Pain

9 Global Pain Management Drugs and Devices Market, By Mode of Purchase
9.1 Introduction
9.2 Prescription-based Devices
9.3 Over-the-counter Devices

10 Global Pain Management Drugs and Devices Market, By Geography
10.1 North America
10.1.1 US
10.1.2 Canada
10.1.3 Mexico
10.2 Europe
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 UK
10.2.5 Spain
10.2.6 Rest of Europe
10.3 Asia Pacific
10.3.1 Japan
10.3.2 China
10.3.3 India
10.3.4 Australia
10.3.5 New Zealand
10.3.6 Rest of Asia Pacific
10.4 Rest of the World
10.4.1 Middle East
10.4.2 Brazil
10.4.3 Argentina
10.4.4 South Africa
10.4.5 Egypt

11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies

12 Company Profiling
12.1 Abbvie Inc.
12.2 Astrazeneca Depomed Inc.
12.3 B. Braun Melsungen AG
12.4 Becton, Dickinson and Company
12.5 Boston Scientific Corporation
12.6 Eli Lilly & Co.
12.7 Glaxosmithkline
12.8 Halyard Health, Inc.
12.9 Hisamitsu Pharmaceutical Co. Inc
12.10 Johnson & Johnson
12.11 Medtronic Inc.
12.12 Medtronic PLC
12.13 Neurotech Na, Inc. (A Subsidiary of Theragen LLC)
12.14 Nevro Corp.
12.15 Novartis International Ag
12.16 Pfizer
12.17 Purdue Pharmaceuticals Lp
12.18 Smiths Medical
12.19 ST. Jude Medical, Inc.

List of Tables
Table 1 Global Pain Management Drugs and Devices Market, By Region (2013-2022) ($MN)
Table 2 Global Pain Management Drugs and Devices Market, By Drug Class (2013-2022) ($MN)
Table 3 Global Pain Management Drugs and Devices Market, By Anti-Migraine Agents (2013-2022) ($MN)
Table 4 Global Pain Management Drugs and Devices Market, By Non-Narcotic Analgesics (2013-2022) ($MN)
Table 5 Global Pain Management Drugs and Devices Market, By Opioids (2013-2022) ($MN)
Table 6 Global Pain Management Drugs and Devices Market, By NSAIDS (2013-2022) ($MN)
Table 7 Global Pain Management Drugs and Devices Market, By Anesthetics (2013-2022) ($MN)
Table 8 Global Pain Management Drugs and Devices Market, By Anticovulsants (2013-2022) ($MN)
Table 9 Global Pain Management Drugs and Devices Market, By Antidepressent (2013-2022) ($MN)
Table 10 Global Pain Management Drugs and Devices Market, By Device Type (2013-2022) ($MN)
Table 11 Global Pain Management Drugs and Devices Market, By Analgesic Infusion Pumps (2013-2022) ($MN)
Table 12 Global Pain Management Drugs and Devices Market, By External Infusion Pumps (2013-2022) ($MN)
Table 13 Global Pain Management Drugs and Devices Market, By Intrathecal Infusion Pumps (2013-2022) ($MN)
Table 14 Global Pain Management Drugs and Devices Market, By Ablation Devices (2013-2022) ($MN)
Table 15 Global Pain Management Drugs and Devices Market, By Cryoablation Devices (2013-2022) ($MN)
Table 16 Global Pain Management Drugs and Devices Market, By Radiofrequency Ablation Devices (2013-2022) ($MN)
Table 17 Global Pain Management Drugs and Devices Market, By Electrical stimulation devices (2013-2022) ($MN)
Table 18 Global Pain Management Drugs and Devices Market, By Neuromuscular Electrical Stimulation (NMES/EMS) Devices (2013-2022) ($MN)
Table 19 Global Pain Management Drugs and Devices Market, By Transcutaneous Electrical Nerve Stimulation (TENS) Devices (2013-2022) ($MN)
Table 20 Global Pain Management Drugs and Devices Market, By Other Electrical Stimulation Devices (2013-2022) ($MN)
Table 21 Global Pain Management Drugs and Devices Market, By Neuromodulation Devices (2013-2022) ($MN)
Table 22 Global Pain Management Drugs and Devices Market, By Sacral Nerve Stimulation Devices (2013-2022) ($MN)
Table 23 Global Pain Management Drugs and Devices Market, By Deep Brain Stimulation Devices (2013-2022) ($MN)
Table 24 Global Pain Management Drugs and Devices Market, By Vagus Nerve Stimulation Devices (2013-2022) ($MN)
Table 25 Global Pain Management Drugs and Devices Market, By Spinal Cord Stimulation (SCS) Devices (2013-2022) ($MN)
Table 26 Global Pain Management Drugs and Devices Market, By Indications (2013-2022) ($MN)
Table 27 Global Pain Management Drugs and Devices Market, By Arthritic pain (2013-2022) ($MN)
Table 28 Global Pain Management Drugs and Devices Market, By Cancer pain (2013-2022) ($MN)
Table 29 Global Pain Management Drugs and Devices Market, By Migraine (2013-2022) ($MN)
Table 30 Global Pain Management Drugs and Devices Market, By Fibromyalgia (2013-2022) ($MN)
Table 31 Global Pain Management Drugs and Devices Market, By Chronic back pain (2013-2022) ($MN)
Table 32 Global Pain Management Drugs and Devices Market, By Neuropathic pain (2013-2022) ($MN)
Table 33 Global Pain Management Drugs and Devices Market, By Post-operative pain (2013-2022) ($MN)
Table 34 Global Pain Management Drugs and Devices Market, By Application (2013-2022) ($MN)
Table 35 Global Pain Management Drugs and Devices Market, By Cancer Pain (2013-2022) ($MN)
Table 36 Global Pain Management Drugs and Devices Market, By Facial Pain and Migraine (2013-2022) ($MN)
Table 37 Global Pain Management Drugs and Devices Market, By Musculoskeletal Pain (2013-2022) ($MN)
Table 38 Global Pain Management Drugs and Devices Market, By Neuropathic Pain (2013-2022) ($MN)
Table 39 Global Pain Management Drugs and Devices Market, By Other Applications (2013-2022) ($MN)
Table 40 Global Pain Management Drugs and Devices Market, By Post-operative Pain (2013-2022) ($MN)
Table 41 Global Pain Management Drugs and Devices Market, By Pregnancy/Labor and Menstrual Pain (2013-2022) ($MN)
Table 42 Global Pain Management Drugs and Devices Market, By Sports Injuries (2013-2022) ($MN)
Table 43 Global Pain Management Drugs and Devices Market, By Trauma Pain (2013-2022) ($MN)
Table 44 Global Pain Management Drugs and Devices Market, By Mode of Purchase (2013-2022) ($MN)
Table 45 Global Pain Management Drugs and Devices Market, By Prescription-based Devices (2013-2022) ($MN)
Table 46 Global Pain Management Drugs and Devices Market, By Over-the-counter Devices (2013-2022) ($MN)
Table 47 North America Pain Management Drugs and Devices Market, By Country (2013-2022) ($MN)
Table 48 North America Pain Management Drugs and Devices Market, By Drug Class (2013-2022) ($MN)
Table 49 North America Pain Management Drugs and Devices Market, By Anti-Migraine Agents (2013-2022) ($MN)
Table 50 North America Pain Management Drugs and Devices Market, By Non-Narcotic Analgesics (2013-2022) ($MN)
Table 51 North America Pain Management Drugs and Devices Market, By Opioids (2013-2022) ($MN)
Table 52 North America Pain Management Drugs and Devices Market, By NSAIDS (2013-2022) ($MN)
Table 53 North America Pain Management Drugs and Devices Market, By Anesthetics (2013-2022) ($MN)
Table 54 North America Pain Management Drugs and Devices Market, By Anticovulsants (2013-2022) ($MN)
Table 55 North America Pain Management Drugs and Devices Market, By Antidepressent (2013-2022) ($MN)
Table 56 North America Pain Management Drugs and Devices Market, By Device Type (2013-2022) ($MN)
Table 57 North America Pain Management Drugs and Devices Market, By Analgesic Infusion Pumps (2013-2022) ($MN)
Table 58 North America Pain Management Drugs and Devices Market, By External Infusion Pumps (2013-2022) ($MN)
Table 59 North America Pain Management Drugs and Devices Market, By Intrathecal Infusion Pumps (2013-2022) ($MN)
Table 60 North America Pain Management Drugs and Devices Market, By Ablation Devices (2013-2022) ($MN)
Table 61 North America Pain Management Drugs and Devices Market, By Cryoablation Devices (2013-2022) ($MN)
Table 62 North America Pain Management Drugs and Devices Market, By Radiofrequency Ablation Devices (2013-2022) ($MN)
Table 63 North America Pain Management Drugs and Devices Market, By Electrical stimulation devices (2013-2022) ($MN)
Table 64 North America Pain Management Drugs and Devices Market, By Neuromuscular Electrical Stimulation (NMES/EMS) Devices (2013-2022) ($MN)
Table 65 North America Pain Management Drugs and Devices Market, By Transcutaneous Electrical Nerve Stimulation (TENS) Devices (2013-2022) ($MN)
Table 66 North America Pain Management Drugs and Devices Market, By Other Electrical Stimulation Devices (2013-2022) ($MN)
Table 67 North America Pain Management Drugs and Devices Market, By Neuromodulation Devices (2013-2022) ($MN)
Table 68 North America Pain Management Drugs and Devices Market, By Sacral Nerve Stimulation Devices (2013-2022) ($MN)
Table 69 North America Pain Management Drugs and Devices Market, By Deep Brain Stimulation Devices (2013-2022) ($MN)
Table 70 North America Pain Management Drugs and Devices Market, By Vagus Nerve Stimulation Devices (2013-2022) ($MN)
Table 71 North America Pain Management Drugs and Devices Market, By Spinal Cord Stimulation (SCS) Devices (2013-2022) ($MN)
Table 72 North America Pain Management Drugs and Devices Market, By Indications (2013-2022) ($MN)
Table 73 North America Pain Management Drugs and Devices Market, By Arthritic pain (2013-2022) ($MN)
Table 74 North America Pain Management Drugs and Devices Market, By Cancer pain (2013-2022) ($MN)
Table 75 North America Pain Management Drugs and Devices Market, By Migraine (2013-2022) ($MN)
Table 76 North America Pain Management Drugs and Devices Market, By Fibromyalgia (2013-2022) ($MN)
Table 77 North America Pain Management Drugs and Devices Market, By Chronic back pain (2013-2022) ($MN)
Table 78 North America Pain Management Drugs and Devices Market, By Neuropathic pain (2013-2022) ($MN)
Table 79 North America Pain Management Drugs and Devices Market, By Post-operative pain (2013-2022) ($MN)
Table 80 North America Pain Management Drugs and Devices Market, By Application (2013-2022) ($MN)
Table 81 North America Pain Management Drugs and Devices Market, By Cancer Pain (2013-2022) ($MN)
Table 82 North America Pain Management Drugs and Devices Market, By Facial Pain and Migraine (2013-2022) ($MN)
Table 83 North America Pain Management Drugs and Devices Market, By Musculoskeletal Pain (2013-2022) ($MN)
Table 84 North America Pain Management Drugs and Devices Market, By Neuropathic Pain (2013-2022) ($MN)
Table 85 North America Pain Management Drugs and Devices Market, By Other Applications (2013-2022) ($MN)
Table 86 North America Pain Management Drugs and Devices Market, By Post-operative Pain (2013-2022) ($MN)
Table 87 North America Pain Management Drugs and Devices Market, By Pregnancy/Labor and Menstrual Pain (2013-2022) ($MN)
Table 88 North America Pain Management Drugs and Devices Market, By Sports Injuries (2013-2022) ($MN)
Table 89 North America Pain Management Drugs and Devices Market, By Trauma Pain (2013-2022) ($MN)
Table 90 North America Pain Management Drugs and Devices Market, By Mode of Purchase (2013-2022) ($MN)
Table 91 North America Pain Management Drugs and Devices Market, By Prescription-based Devices (2013-2022) ($MN)
Table 92 North America Pain Management Drugs and Devices Market, By Over-the-counter Devices (2013-2022) ($MN)
Table 93 Europe Pain Management Drugs and Devices Market, By Country (2013-2022) ($MN)
Table 94 Europe Pain Management Drugs and Devices Market, By Drug Class (2013-2022) ($MN)
Table 95 Europe Pain Management Drugs and Devices Market, By Anti-Migraine Agents (2013-2022) ($MN)
Table 96 Europe Pain Management Drugs and Devices Market, By Non-Narcotic Analgesics (2013-2022) ($MN)
Table 97 Europe Pain Management Drugs and Devices Market, By Opioids (2013-2022) ($MN)
Table 98 Europe Pain Management Drugs and Devices Market, By NSAIDS (2013-2022) ($MN)
Table 99 Europe Pain Management Drugs and Devices Market, By Anesthetics (2013-2022) ($MN)
Table 100 Europe Pain Management Drugs and Devices Market, By Anticovulsants (2013-2022) ($MN)
Table 101 Europe Pain Management Drugs and Devices Market, By Antidepressent (2013-2022) ($MN)
Table 102 Europe Pain Management Drugs and Devices Market, By Device Type (2013-2022) ($MN)
Table 103 Europe Pain Management Drugs and Devices Market, By Analgesic Infusion Pumps (2013-2022) ($MN)
Table 104 Europe Pain Management Drugs and Devices Market, By External Infusion Pumps (2013-2022) ($MN)
Table 105 Europe Pain Management Drugs and Devices Market, By Intrathecal Infusion Pumps (2013-2022) ($MN)
Table 106 Europe Pain Management Drugs and Devices Market, By Ablation Devices (2013-2022) ($MN)
Table 107 Europe Pain Management Drugs and Devices Market, By Cryoablation Devices (2013-2022) ($MN)
Table 108 Europe Pain Management Drugs and Devices Market, By Radiofrequency Ablation Devices (2013-2022) ($MN)
Table 109 Europe Pain Management Drugs and Devices Market, By Electrical stimulation devices (2013-2022) ($MN)
Table 110 Europe Pain Management Drugs and Devices Market, By Neuromuscular Electrical Stimulation (NMES/EMS) Devices (2013-2022) ($MN)
Table 111 Europe Pain Management Drugs and Devices Market, By Transcutaneous Electrical Nerve Stimulation (TENS) Devices (2013-2022) ($MN)
Table 112 Europe Pain Management Drugs and Devices Market, By Other Electrical Stimulation Devices (2013-2022) ($MN)
Table 113 Europe Pain Management Drugs and Devices Market, By Neuromodulation Devices (2013-2022) ($MN)
Table 114 Europe Pain Management Drugs and Devices Market, By Sacral Nerve Stimulation Devices (2013-2022) ($MN)
Table 115 Europe Pain Management Drugs and Devices Market, By Deep Brain Stimulation Devices (2013-2022) ($MN)
Table 116 Europe Pain Management Drugs and Devices Market, By Vagus Nerve Stimulation Devices (2013-2022) ($MN)
Table 117 Europe Pain Management Drugs and Devices Market, By Spinal Cord Stimulation (SCS) Devices (2013-2022) ($MN)
Table 118 Europe Pain Management Drugs and Devices Market, By Indications (2013-2022) ($MN)
Table 119 Europe Pain Management Drugs and Devices Market, By Arthritic pain (2013-2022) ($MN)
Table 120 Europe Pain Management Drugs and Devices Market, By Cancer pain (2013-2022) ($MN)
Table 121 Europe Pain Management Drugs and Devices Market, By Migraine (2013-2022) ($MN)
Table 122 Europe Pain Management Drugs and Devices Market, By Fibromyalgia (2013-2022) ($MN)
Table 123 Europe Pain Management Drugs and Devices Market, By Chronic back pain (2013-2022) ($MN)
Table 124 Europe Pain Management Drugs and Devices Market, By Neuropathic pain (2013-2022) ($MN)
Table 125 Europe Pain Management Drugs and Devices Market, By Post-operative pain (2013-2022) ($MN)
Table 126 Europe Pain Management Drugs and Devices Market, By Application (2013-2022) ($MN)
Table 127 Europe Pain Management Drugs and Devices Market, By Cancer Pain (2013-2022) ($MN)
Table 128 Europe Pain Management Drugs and Devices Market, By Facial Pain and Migraine (2013-2022) ($MN)
Table 129 Europe Pain Management Drugs and Devices Market, By Musculoskeletal Pain (2013-2022) ($MN)
Table 130 Europe Pain Management Drugs and Devices Market, By Neuropathic Pain (2013-2022) ($MN)
Table 131 Europe Pain Management Drugs and Devices Market, By Other Applications (2013-2022) ($MN)
Table 132 Europe Pain Management Drugs and Devices Market, By Post-operative Pain (2013-2022) ($MN)
Table 133 Europe Pain Management Drugs and Devices Market, By Pregnancy/Labor and Menstrual Pain (2013-2022) ($MN)
Table 134 Europe Pain Management Drugs and Devices Market, By Sports Injuries (2013-2022) ($MN)
Table 135 Europe Pain Management Drugs and Devices Market, By Trauma Pain (2013-2022) ($MN)
Table 136 Europe Pain Management Drugs and Devices Market, By Mode of Purchase (2013-2022) ($MN)
Table 137 Europe Pain Management Drugs and Devices Market, By Prescription-based Devices (2013-2022) ($MN)
Table 138 Europe Pain Management Drugs and Devices Market, By Over-the-counter Devices (2013-2022) ($MN)
Table 139 Asia Pacific Pain Management Drugs and Devices Market, By Country (2013-2022) ($MN)
Table 140 Asia Pacific Pain Management Drugs and Devices Market, By Drug Class (2013-2022) ($MN)
Table 141 Asia Pacific Pain Management Drugs and Devices Market, By Anti-Migraine Agents (2013-2022) ($MN)
Table 142 Asia Pacific Pain Management Drugs and Devices Market, By Non-Narcotic Analgesics (2013-2022) ($MN)
Table 143 Asia Pacific Pain Management Drugs and Devices Market, By Opioids (2013-2022) ($MN)
Table 144 Asia Pacific Pain Management Drugs and Devices Market, By NSAIDS (2013-2022) ($MN)
Table 145 Asia Pacific Pain Management Drugs and Devices Market, By Anesthetics (2013-2022) ($MN)
Table 146 Asia Pacific Pain Management Drugs and Devices Market, By Anticovulsants (2013-2022) ($MN)
Table 147 Asia Pacific Pain Management Drugs and Devices Market, By Antidepressent (2013-2022) ($MN)
Table 148 Asia Pacific Pain Management Drugs and Devices Market, By Device Type (2013-2022) ($MN)
Table 149 Asia Pacific Pain Management Drugs and Devices Market, By Analgesic Infusion Pumps (2013-2022) ($MN)
Table 150 Asia Pacific Pain Management Drugs and Devices Market, By External Infusion Pumps (2013-2022) ($MN)
Table 151 Asia Pacific Pain Management Drugs and Devices Market, By Intrathecal Infusion Pumps (2013-2022) ($MN)
Table 152 Asia Pacific Pain Management Drugs and Devices Market, By Ablation Devices (2013-2022) ($MN)
Table 153 Asia Pacific Pain Management Drugs and Devices Market, By Cryoablation Devices (2013-2022) ($MN)
Table 154 Asia Pacific Pain Management Drugs and Devices Market, By Radiofrequency Ablation Devices (2013-2022) ($MN)
Table 155 Asia Pacific Pain Management Drugs and Devices Market, By Electrical stimulation devices (2013-2022) ($MN)
Table 156 Asia Pacific Pain Management Drugs and Devices Market, By Neuromuscular Electrical Stimulation (NMES/EMS) Devices (2013-2022) ($MN)
Table 157 Asia Pacific Pain Management Drugs and Devices Market, By Transcutaneous Electrical Nerve Stimulation (TENS) Devices (2013-2022) ($MN)
Table 158 Asia Pacific Pain Management Drugs and Devices Market, By Other Electrical Stimulation Devices (2013-2022) ($MN)
Table 159 Asia Pacific Pain Management Drugs and Devices Market, By Neuromodulation Devices (2013-2022) ($MN)
Table 160 Asia Pacific Pain Management Drugs and Devices Market, By Sacral Nerve Stimulation Devices (2013-2022) ($MN)
Table 161 Asia Pacific Pain Management Drugs and Devices Market, By Deep Brain Stimulation Devices (2013-2022) ($MN)
Table 162 Asia Pacific Pain Management Drugs and Devices Market, By Vagus Nerve Stimulation Devices (2013-2022) ($MN)
Table 163 Asia Pacific Pain Management Drugs and Devices Market, By Spinal Cord Stimulation (SCS) Devices (2013-2022) ($MN)
Table 164 Asia Pacific Pain Management Drugs and Devices Market, By Indications (2013-2022) ($MN)
Table 165 Asia Pacific Pain Management Drugs and Devices Market, By Arthritic pain (2013-2022) ($MN)
Table 166 Asia Pacific Pain Management Drugs and Devices Market, By Cancer pain (2013-2022) ($MN)
Table 167 Asia Pacific Pain Management Drugs and Devices Market, By Migraine (2013-2022) ($MN)
Table 168 Asia Pacific Pain Management Drugs and Devices Market, By Fibromyalgia (2013-2022) ($MN)
Table 169 Asia Pacific Pain Management Drugs and Devices Market, By Chronic back pain (2013-2022) ($MN)
Table 170 Asia Pacific Pain Management Drugs and Devices Market, By Neuropathic pain (2013-2022) ($MN)
Table 171 Asia Pacific Pain Management Drugs and Devices Market, By Post-operative pain (2013-2022) ($MN)
Table 172 Asia Pacific Pain Management Drugs and Devices Market, By Application (2013-2022) ($MN)
Table 173 Asia Pacific Pain Management Drugs and Devices Market, By Cancer Pain (2013-2022) ($MN)
Table 174 Asia Pacific Pain Management Drugs and Devices Market, By Facial Pain and Migraine (2013-2022) ($MN)
Table 175 Asia Pacific Pain Management Drugs and Devices Market, By Musculoskeletal Pain (2013-2022) ($MN)
Table 176 Asia Pacific Pain Management Drugs and Devices Market, By Neuropathic Pain (2013-2022) ($MN)
Table 177 Asia Pacific Pain Management Drugs and Devices Market, By Other Applications (2013-2022) ($MN)
Table 178 Asia Pacific Pain Management Drugs and Devices Market, By Post-operative Pain (2013-2022) ($MN)
Table 179 Asia Pacific Pain Management Drugs and Devices Market, By Pregnancy/Labor and Menstrual Pain (2013-2022) ($MN)
Table 180 Asia Pacific Pain Management Drugs and Devices Market, By Sports Injuries (2013-2022) ($MN)
Table 181 Asia Pacific Pain Management Drugs and Devices Market, By Trauma Pain (2013-2022) ($MN)
Table 182 Asia Pacific Pain Management Drugs and Devices Market, By Mode of Purchase (2013-2022) ($MN)
Table 183 Asia Pacific Pain Management Drugs and Devices Market, By Prescription-based Devices (2013-2022) ($MN)
Table 184 Asia Pacific Pain Management Drugs and Devices Market, By Over-the-counter Devices (2013-2022) ($MN)
Table 185 RoW Pain Management Drugs and Devices Market, By Country (2013-2022) ($MN)
Table 186 RoW Pain Management Drugs and Devices Market, By Drug Class (2013-2022) ($MN)
Table 187 RoW Pain Management Drugs and Devices Market, By Anti-Migraine Agents (2013-2022) ($MN)
Table 188 RoW Pain Management Drugs and Devices Market, By Non-Narcotic Analgesics (2013-2022) ($MN)
Table 189 RoW Pain Management Drugs and Devices Market, By Opioids (2013-2022) ($MN)
Table 190 RoW Pain Management Drugs and Devices Market, By NSAIDS (2013-2022) ($MN)
Table 191 RoW Pain Management Drugs and Devices Market, By Anesthetics (2013-2022) ($MN)
Table 192 RoW Pain Management Drugs and Devices Market, By Anticovulsants (2013-2022) ($MN)
Table 193 RoW Pain Management Drugs and Devices Market, By Antidepressent (2013-2022) ($MN)
Table 194 RoW Pain Management Drugs and Devices Market, By Device Type (2013-2022) ($MN)
Table 195 RoW Pain Management Drugs and Devices Market, By Analgesic Infusion Pumps (2013-2022) ($MN)
Table 196 RoW Pain Management Drugs and Devices Market, By External Infusion Pumps (2013-2022) ($MN)
Table 197 RoW Pain Management Drugs and Devices Market, By Intrathecal Infusion Pumps (2013-2022) ($MN)
Table 198 RoW Pain Management Drugs and Devices Market, By Ablation Devices (2013-2022) ($MN)
Table 199 RoW Pain Management Drugs and Devices Market, By Cryoablation Devices (2013-2022) ($MN)
Table 200 RoW Pain Management Drugs and Devices Market, By Radiofrequency Ablation Devices (2013-2022) ($MN)
Table 201 RoW Pain Management Drugs and Devices Market, By Electrical stimulation devices (2013-2022) ($MN)
Table 202 RoW Pain Management Drugs and Devices Market, By Neuromuscular Electrical Stimulation (NMES/EMS) Devices (2013-2022) ($MN)
Table 203 RoW Pain Management Drugs and Devices Market, By Transcutaneous Electrical Nerve Stimulation (TENS) Devices (2013-2022) ($MN)
Table 204 RoW Pain Management Drugs and Devices Market, By Other Electrical Stimulation Devices (2013-2022) ($MN)
Table 205 RoW Pain Management Drugs and Devices Market, By Neuromodulation Devices (2013-2022) ($MN)
Table 206 RoW Pain Management Drugs and Devices Market, By Sacral Nerve Stimulation Devices (2013-2022) ($MN)
Table 207 RoW Pain Management Drugs and Devices Market, By Deep Brain Stimulation Devices (2013-2022) ($MN)
Table 208 RoW Pain Management Drugs and Devices Market, By Vagus Nerve Stimulation Devices (2013-2022) ($MN)
Table 209 RoW Pain Management Drugs and Devices Market, By Spinal Cord Stimulation (SCS) Devices (2013-2022) ($MN)
Table 210 RoW Pain Management Drugs and Devices Market, By Indications (2013-2022) ($MN)
Table 211 RoW Pain Management Drugs and Devices Market, By Arthritic pain (2013-2022) ($MN)
Table 212 RoW Pain Management Drugs and Devices Market, By Cancer pain (2013-2022) ($MN)
Table 213 RoW Pain Management Drugs and Devices Market, By Migraine (2013-2022) ($MN)
Table 214 RoW Pain Management Drugs and Devices Market, By Fibromyalgia (2013-2022) ($MN)
Table 215 RoW Pain Management Drugs and Devices Market, By Chronic back pain (2013-2022) ($MN)
Table 216 RoW Pain Management Drugs and Devices Market, By Neuropathic pain (2013-2022) ($MN)
Table 217 RoW Pain Management Drugs and Devices Market, By Post-operative pain (2013-2022) ($MN)
Table 218 RoW Pain Management Drugs and Devices Market, By Application (2013-2022) ($MN)
Table 219 RoW Pain Management Drugs and Devices Market, By Cancer Pain (2013-2022) ($MN)
Table 220 RoW Pain Management Drugs and Devices Market, By Facial Pain and Migraine (2013-2022) ($MN)
Table 221 RoW Pain Management Drugs and Devices Market, By Musculoskeletal Pain (2013-2022) ($MN)
Table 222 RoW Pain Management Drugs and Devices Market, By Neuropathic Pain (2013-2022) ($MN)
Table 223 RoW Pain Management Drugs and Devices Market, By Other Applications (2013-2022) ($MN)
Table 224 RoW Pain Management Drugs and Devices Market, By Post-operative Pain (2013-2022) ($MN)
Table 225 RoW Pain Management Drugs and Devices Market, By Pregnancy/Labor and Menstrual Pain (2013-2022) ($MN)
Table 226 RoW Pain Management Drugs and Devices Market, By Sports Injuries (2013-2022) ($MN)
Table 227 RoW Pain Management Drugs and Devices Market, By Trauma Pain (2013-2022) ($MN)
Table 228 RoW Pain Management Drugs and Devices Market, By Mode of Purchase (2013-2022) ($MN)
Table 229 RoW Pain Management Drugs and Devices Market, By Prescription-based Devices (2013-2022) ($MN)
Table 230 RoW Pain Management Drugs and Devices Market, By Over-the-counter Devices (2013-2022) ($MN)



*** レポートのキーワード ***

疼痛管理薬、疼痛管理装置、癌性疼痛、顔面痛、頭痛、筋骨格痛、神経障害性疼痛

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • コンクリート用アンカーシステムの世界市場予測2019-2024
    Concrete Anchoring Systems are used to connect structural and non-structural elements to the concrete. They are designed for quick, safe, secure fastening for a variety of jobs in concrete, brick and cinder block/masonry. According to this study, over the next five years the Concrete Anchoring Syste …
  • セラミック基複合材料(CMC)の世界市場規模・シェア・開発・成長・需要予測
    The high cost of ceramic fibers has greatly influenced the market growth. Unlike the carbon fiber, which is used in most of the metal and polymer composites and thus, is produced in bulk, other ceramic fibers are produced in small quantities, which refrains them from enjoying the cost benefits of ma …
  • ポリイソブチレン無水コハク酸の世界及び中国市場 2018年
    The 'Global and Chinese Polyisobutylene Succinic Anhydride Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Polyisobutylene Succinic Anhydride industry with a focus on the Chinese market. The report provides key statistics on the mar …
  • 世界のピストン圧力スイッチ市場2016
    Notes:Production, means the output of Piston Pressure Switches Revenue, means the sales value of Piston Pressure Switches This report studies Piston Pressure Switches in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global …
  • 養殖業の世界市場
    This report analyzes the worldwide markets for Aquaculture in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, China, Asia-Pacific, Middle East & Africa and Latin America. Annual estimates and forecasts are provided for the period 2016 through 2024 …
  • ヘアカーラーの世界市場
    Hair Rollers Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, …
  • 世界のミルクティーパウダー市場2016
    The Global Milk Tea Powder Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Milk Tea Powder industry. Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. …
  • 米国の細菌性結膜炎治療薬市場:産業分析、パイプライン、市場規模、シェア、成長、動向、予測
    Bacterial conjunctivitis is a commonly encountered eye problem across the world, caused by various bacterial strains such as streptococci, staphylococci, chlamydial, and gonococci organisms. Majority of the cases of bacterial conjunctivitis are self-limited and acute and not a major cause of morbidi …
  • エンジンナセルの世界市場2016
    The Global Engine Nacelle Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Engine Nacelle industry. Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. Th …
  • 世界のエリトリトール市場2017
    Notes:Sales, means the sales volume of Erythritol Revenue, means the sales value of Erythritol This report studies sales (consumption) of Erythritol in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue a …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(SMRC611059 )"疼痛管理薬&装置の世界市場見通し:癌性疼痛、顔面痛、頭痛、筋骨格痛、神経障害性疼痛" (英文:Pain Management Drugs and Devices - Global Market Outlook (2016-2022))はStratistics MRC社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。